NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) resulting from allegations that Milestone may have issued materially misleading business information to the investing

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of FMC Corporation (NYSE: FMC) between November 2, 2022 and October 20, 2023, both dates inclusive (the “Class Period”), of the important January 8, 2024 lead plaintiff

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LivePerson, Inc. (NASDAQ: LPSN) between May 10, 2022 and March 16, 2023, both dates inclusive (the “Class Period”), of the important January 30, 2024 lead plaintiff deadline.

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Generac Holdings Inc. (NYSE: GNRC) between May 3, 2023 and August 3, 2023, both dates inclusive (the “Class Period”), of the important January 22, 2024 lead

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of James River Group Holdings, Ltd. (NASDAQ: JRVR) between August 7, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important January 12, 2024

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of General Motors Company (NYSE: GM) between February 2, 2022 and October 26, 2023, both dates inclusive (the “Class Period”), of the February 6, 2024 lead plaintiff deadline.